Hidekazu Takeno

This inventor holds 26 USPTO granted patents, primarily in Peptide Chemistry. Top assignees: Fujisawa Pharmaceutical Company, Ltd., Other. Active years: 1980-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidekazu Takeno. Retrieved from https://idiyas.com/inventor/hidekazu-takeno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 26

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 8

Forward Citations = 187(Granted Patents)

Location History:

Kita, JP (1980)
Higashimuki-kitamachi, Nara, JP (1981)
Higashimuki-kitamachi, JP (1982)
Nara, JP (1980 - 1988)
Tenri, JP (1982 - 1989)

Company Filing History:

25 out of 940

Fujisawa Pharmaceutical Company, Ltd.

patents

1 out of 834,513

Other

patents

Years Active: 1980-1989

Loading Chart...

Areas of Expertise:

Peptide

Prodrug Compounds

Cephalosporin Analogues

Streptomyces Strains

Azetidinone Compounds

Oxazole Derivatives

Antimicrobial Compositions

Hydroxyaminohydrocarbonphosphonic Acids

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4801580 - Peptide, process for preparation thereof and use thereof (1989-01-31),

2. 4772594 - Prodrug compounds, process for the preparation thereof and sustained (1988-09-20),

3. 4749691 - Peptide, process for preparation thereof and use thereof (1988-06-07),

4. 4666890 - Peptide, process for preparation thereof and use thereof (1987-05-19),

5. 4539155 - New peptide, process for preparation thereof and use thereof (1985-09-03),

6. 4512980 - Peptide, process for preparation thereof and use thereof (1985-04-23),

7. 4504584 - Cultures of novel strains of Streptomyces (1985-03-12),

8. 4497729 - Peptide, process for preparation thereof and use thereof (1985-02-05),

9. 4493794 - Peptide, process for preparation thereof and use thereof (1985-01-15),

10. 4487763 - Peptide, process for preparation thereof and use thereof (1984-12-11),

11. 4476050 - Peptide, process for preparation thereof and use thereof (1984-10-09),

12. 4472309 - 2-Azetidinone compounds and processes for preparation thereof (1984-09-18),

13. 4460502 - Peptide, process for preparation thereof and use thereof (1984-07-17),

14. 4458078 - Oxazole derivatives (1984-07-03),

15. 4354966 - Peptides, process for preparation thereof and use thereof (1982-10-19),

Title: Innovations and Contributions of Hidekazu Takeno

Introduction

Hidekazu Takeno is a notable inventor from Tenri, Japan, recognized for his significant contributions to the field of pharmacology. With 26 patents to his name, Takeno has made remarkable strides in the development of novel peptides and prodrug compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, one stands out: the invention of novel peptides with pharmacological activity, which is described by a specific formula. This innovation aims to provide beneficial therapeutic effects through the use of advanced peptides. Another critical patent involves a novel prodrug compound beneficial for treating tumors, showcasing Takeno's commitment to addressing significant health challenges through innovation.

Career Highlights

Throughout his career, Hidekazu Takeno has been affiliated with Fujisawa Pharmaceutical Company, Ltd., where he has greatly contributed to the development of pharmaceutical innovations. His expertise and dedication have positioned him as a leading figure in the field of medication development.

Collaborations

In addition to his individual contributions, Takeno has collaborated with esteemed colleagues such as Masashi Hashimoto and Keiji Hemmi. These partnerships have likely enhanced his research and broadened the scope of his innovative work in pharmacology.

Conclusion

Hidekazu Takeno’s work exemplifies the impact of innovation in healthcare. With a focus on developing effective therapeutic compounds, his contributions reflect a dedication to improving the quality of life through science. As he continues to innovate, his ongoing work promises to lead to further advancements in the field of pharmaceuticals.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]